3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
19
Colonic Neoplasms
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
7
Stomach Neoplasms
6
Rectal Neoplasms
5
Adenocarcinoma Of Esophagus
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Large B-Cell, Diffuse
4
Cholangiocarcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Endometrial Neoplasms
3
Adenocarcinoma
3
Recurrence
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Prostatic Neoplasms
1
Interventions
fludarabine
10
Specimen Handling
8
Cytarabine
8
Cyclophosphamide
8
Biopsy
8
fludarabine phosphate
7
Whole-Body Irradiation
7
venetoclax
6
Injections
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
decitabine and cedazuridine drug combination
4
X-Rays
4
Tacrolimus
4
Stem Cell Transplantation
4
Cyclosporine
4
CPX-351
4
Peripheral Blood Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
Idarubicin
3
Decitabine
3
treosulfan
2
ruxolitinib
2
luspatercept
2
ivosidenib
2
gilteritinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.